Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes

Experimental Eye Research

Volumn 98, Issue 1, 2012, Pages 23-27

  Durairaj, Chandrasekar ^a,e   Chastain, James E ^b   Kompella, Uday B ^a,c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b ALCON RESEARCH LTD   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d The University of Colorado Denver   (United States)

^e ALLERGAN INC   (United States)

Author keywords

Choroid; Dog; Human; Melanin content; Minipig; Rabbit; Retina; Sclera

Indexed keywords

MELANIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; COLORIMETRY; DOG; DRUG DELIVERY SYSTEM; HAPLORHINI; HUMAN; HUMAN TISSUE; MINIPIG; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; RETINA; SCLERA;

ANIMALS; CHOROID; COLORIMETRY; DOGS; EYE PROTEINS; HUMANS; MACACA FASCICULARIS; MELANINS; RABBITS; RETINA; RETINAL PIGMENT EPITHELIUM; SCLERA; SWINE; SWINE, MINIATURE;

EID: 84860227011     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.03.004     Document Type: Article

References (25)

1. Amrite A., Pugazhenthi V., Cheruvu N., Kompella U. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opin. Drug Deliv. 2010, 7:631-645.
2. Amrite A.C., Edelhauser H.F., Kompella U.B. Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest. Ophthalmol. Vis. Sci. 2008, 49:320-332.
3. Araie M., Takase M., Sakai Y., Ishii Y., Yokoyama Y., Kitagawa M. Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment. Jpn. J. Ophthalmol. 1982, 26:248-263.
4. Ayalasomayajula S.P., Kompella U.B. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration. Pharm. Res. 2004, 21:1797-1804.
5. Baranano D.E., Kim S.J., Edelhauser H.F., Durairaj C., Kompella U., Handa J.T. Efficacy and pharmacokinetics of intravitreal Nonsteroidal Anti-Inflammatory drugs for Intraocular inflammation. Br. J. Ophthalmol. 2009.
6. Cheruvu N.P., Amrite A.C., Kompella U.B. Effect of eye pigmentation on transscleral drug delivery. Invest. Ophthalmol. Vis. Sci. 2008, 49:333-341.
7. Cochereau-Massin I., Bauchet J., Faurisson F., Vallois J.M., Lacombe P., Pocidalo J.J. Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrob. Agents Chemother. 1991, 35:1112-1115.
8. Csillag A.L. The organ of vision. Atlas of the Sensory Organs: Functional and Clinical Anatomy 2005, 89. Humana Press Inc., New Jersey. A.L. Csillag (Ed.).
9. Durairaj C., Kim S.J., Edelhauser H.F., Shah J.C., Kompella U.B. Influence of Dosage Form on the intravitreal pharmacokinetics of Diclofenac. Invest. Ophthalmol. Vis. Sci. 2009.
10. Durairaj C., Shah J.C., Senapati S., Kompella U.B. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR). Pharm. Res. 2009, 26:1236-1260.
11. Hughes P.M., Krishnamoorthy R., Mitra A.K. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 1996, 12:209-224.
12. Kadam R.S., Cheruvu N.P., Edelhauser H.F., Kompella U.B. Sclera-choroid-RPE transport of eight beta-blockers in human, bovine, porcine, rabbit, and rat models. Invest. Ophthalmol. Vis. Sci. 2011.
13. Kadam R.S., Kompella U.B. Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve. J. Pharmacol. Exp. Ther. 2010, 332:1107-1120.
14. Kane A., Barza M., Baum J. Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. Invest. Ophthalmol. Vis. Sci. 1981, 20:593-597.
15. Kim E.S., Durairaj C., Kadam R.S., Lee S.J., Mo Y., Geroski D.H., Kompella U.B., Edelhauser H.F. Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm. Res. 2009, 26:1155-1161.
16. Kompella U.B., Li X., Zhan G., Lee S.S. Influence of intravitreal implant location on ocular disposition of fluocinolone acetonide. Invest. Ophthalmol. Vis. Sci. 2009, pp. E-Abstract 5971.
17. Kompella U.B. Drug delivery to the back of the eye. Arch. Soc. Esp. Oftalmol. 2007, 82(667-668):669-670.
18. Menon I.A., Wakeham D.C., Persad S.D., Avaria M., Trope G.E., Basu P.K. Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. J. Ocul. Pharmacol. 1992, 8:35-42.
19. Nofsinger J.B., Forest S.E., Eibest L.M., Gold K.A., Simon J.D. Probing the building blocks of eumelanins using scanning electron microscopy. Pigment Cell Res. 2000, 13:179-184.
20. Perkins R.J., Liu W., Drusano G., Madu A., Mayers M., Madu C., Miller M.H. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents Chemother. 1995, 39:1493-1498.
21. Potts A.M. The concentration of phenothiazines in the eye of experimental animals. Invest. Ophthalmol. 1962, 1:522-530.
22. Rubin L.F., Weisse I. Species differences relevant for ocular toxicity studies. Manual of Oculotoxicity Testing of Drugs 1992, 177-191. Gustav Fischer Verlag, Stuttgart. O. Hockwin, K. Green, L.F. Rubin (Eds.).
23. Salazar M., Shimada K., Patil P.N. Iris pigmentation and atropine mydriasis. J. Pharmacol. Exp. Ther. 1976, 197:79-88.
24. Schmidt S.Y., Peisch R.D. Melanin concentration in normal human retinal pigment epithelium. Regional variation and age-related reduction. Invest. Ophthalmol. Vis. Sci. 1986, 27:1063-1067.
25. Solans C., Bregante M.A., Garcia M.A., Perez S. Ocular penetration of grepafloxacin after intravitreal administration in albino and pigmented rabbits. Chemotherapy 2004, 50:133-137.